177 related articles for article (PubMed ID: 35664745)
1. Survival of Patients Subjected to Hepatectomy After Spontaneous Rupture of Hepatocellular Carcinoma: A Meta-analysis of High-quality Propensity Score Matching Studies.
Huang X; Jia C; Xu L; Bi X; Lai F; Huang Z; Li X; Yin X; Ni Y; Che X
Front Oncol; 2022; 12():877091. PubMed ID: 35664745
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study.
Zhang SY; Guo DZ; Zhang X; Fan J; Zhou J; Huang A
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8889-8896. PubMed ID: 37154926
[TBL] [Abstract][Full Text] [Related]
3. Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma.
Wang W; Meng T; Chen Y; Xu YC; Zhao YJ; Zhang Y; Yang MY; Zhang ZH; Huang F; Zhao HC; Geng XP; Zhu LX
Hepatobiliary Surg Nutr; 2022 Dec; 11(6):808-821. PubMed ID: 36523928
[TBL] [Abstract][Full Text] [Related]
4. Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: A propensity matched analysis comparing ruptured versus non-ruptured tumors.
Chua DW; Koh YX; Allen JC; Chan CY; Lee SY; Cheow PC; Jeyaraj P; Teo JY; Chow PK; Chung AY; Ooi LL; Goh BKP
Eur J Surg Oncol; 2019 Sep; 45(9):1652-1659. PubMed ID: 31003720
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Influence of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma After Hepatectomy: A Meta-Analysis of Observational Studies.
Xu J; Hong J; Wang Y; Zhou L; Xu B; Si Y; He Y; Chen Y
Front Surg; 2021; 8():769233. PubMed ID: 34869566
[No Abstract] [Full Text] [Related]
6. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy.
Wu JJ; Zhu P; Zhang ZG; Zhang BX; Shu C; Mba'nbo-Koumpa AA; Zhang ZW; Huang ZY; Zhang WG; Lau WY; Chen XP
Eur J Surg Oncol; 2019 Oct; 45(10):1887-1894. PubMed ID: 31405632
[TBL] [Abstract][Full Text] [Related]
7. Early-Stage Ruptured Hepatocellular Carcinoma With Different Tumor Diameters: Small Tumors Have a Better Prognosis.
Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Zhang B; Zhu P
Front Oncol; 2022; 12():865696. PubMed ID: 35656507
[TBL] [Abstract][Full Text] [Related]
8. The role of hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a pilot study.
Ruan S; Shi N; Chen Z; Han H; Wang H; Jin L; Zou Y; Zhang Y; Yu M; Jin H
Ann Transl Med; 2020 Sep; 8(18):1132. PubMed ID: 33240981
[TBL] [Abstract][Full Text] [Related]
9. Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy.
Chen JL; Chen YS; Ker CG
World J Gastrointest Surg; 2023 Feb; 15(2):258-272. PubMed ID: 36896302
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
11. Comparison of survival and post-operation outcomes for minimally invasive versus open hepatectomy in hepatocellular carcinoma: A systematic review and meta-analysis of case-matched studies.
Fu B; Zhang JR; Han PS; Zhang YM
Front Oncol; 2022; 12():1021804. PubMed ID: 36338679
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
13. Transarterial embolization followed by staged hepatectomy versus emergency hepatectomy for ruptured HCC: a meta-analysis.
Pan T; Gao F; Huang X; Xu X
Clin Transl Oncol; 2024 Jan; 26(1):155-170. PubMed ID: 37328589
[TBL] [Abstract][Full Text] [Related]
14. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.
Zhu Q; Li J; Yan JJ; Huang L; Wu MC; Yan YQ
World J Gastroenterol; 2012 Dec; 18(48):7302-7. PubMed ID: 23326137
[TBL] [Abstract][Full Text] [Related]
15. Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy.
Lee HS; Choi GH; Kang DR; Han KH; Ahn SH; Kim DY; Park JY; Kim SU; Choi JS
World J Surg; 2014 Aug; 38(8):2070-8. PubMed ID: 24663479
[TBL] [Abstract][Full Text] [Related]
16. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
[TBL] [Abstract][Full Text] [Related]
18. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
19. Conditional survival in patients with spontaneous tumor rupture of hepatocellular carcinoma after partial hepatectomy: a propensity score matching analysis.
Zhu Q; Qiao G; Xu C; Yu X; Zhao J; Yu Z; Hu M; Yang Y; Wang L; Lu M; Hu F; Cheng Z; Zhou J
HPB (Oxford); 2019 Jun; 21(6):722-730. PubMed ID: 30389432
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Spontaneous Rupture of Hepatocellular Carcinoma and Clinical Outcomes Following Hepatectomy.
Chen Y; Guo D; Li X; Xu C; Zhu Q
Front Oncol; 2022; 12():820867. PubMed ID: 35155255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
